• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利南部农村地区初级保健患者胆固醇管理情况的审计

Audit of cholesterol management among primary care patients in rural southern Italy.

作者信息

Buono Nicola, Petrazzuoli Ferdinando, D'Addio Filippo, Farinaro Carmine, Soler Jean Karl

机构信息

National Italian Society of Medical Education In General Practice, Caserta, Italy.

出版信息

Rural Remote Health. 2013 Oct-Dec;13(4):2225. Epub 2013 Dec 1.

PMID:24289737
Abstract

INTRODUCTION

There has not yet been an audit of achievement rates of therapeutic targets for cholesterol management in the rural Italian primary care setting. The purpose of this study was to measure the percentage of patients with hypercholesterolaemia in a rural primary care setting in southern Italy, classify their risk category and measure the proportions of those patients who achieved optimal cholesterol levels according to the Adult Treatment Panel III guidelines.

METHODS

The audit was completed using records from 1 January 2005 to 31 December 2007. An electronic search key was entered into the electronic clinical records of 10 family doctors in a rural area of southern Italy for subjects with a diagnosis of or being treated for hypercholesterolaemia. A total of 194 hypercholesterolaemic patients were randomly selected from a cohort of patients registered with these family doctors. The low density lipoprotein cholesterol (LDL-C) target level was 100 mg/dL (2.6 mmol/L) in patients with existing cardiovascular disease, 130 mg/dL (3.3 mmol/L) for patients with ≥2 risk factors, and 160 mg/dL (4.1 mmol/L) for all other patients. The results regarding the efficacy of the therapy were categorised as follows: (1) on target, LDL-C lower or equal to levels of affiliated class; (2) poor control, 1-30 mg/dL (0.03-0.78 mmol/L) above the target level of LDL-C; (3) very poor control, ≥31 mg/dL (≥0.8 mmol/L) above the LDL-C target level.

RESULTS

The average age of the hypercholesterolaemic patients included in the study was 62.0 ± 9.0 years; 55% were males, 30% were smokers, 71.3% suffered from hypertension, 46.3% had diabetes, 39.9% were obese and 31.9% had a family history of coronary disease. There were 114 subjects in Class I (personal history of coronary disease, cardiovascular risk ≥ 20, diabetes mellitus) LDL-C target level. Of these patients, 24.6% were at target, 30.7% had poor control and 44.7% had very poor control. A total of 42.3% of the subjects examined with the score system adopted by the Italian Heart Project showed levels of cardiovascular risk between 5% and 19% and were not eligible for a free prescription of lipid-lowering drugs.

CONCLUSIONS

These data suggest that cholesterol management in this rural area is not always optimal in patients with high cardiovascular risk. Italian healthcare regulation seems to be a barrier to drug prescription and it may influence optimal LDL-C control.

摘要

引言

意大利农村基层医疗环境中胆固醇管理治疗目标达成率尚未得到审计。本研究的目的是测量意大利南部农村基层医疗环境中高胆固醇血症患者的百分比,对他们的风险类别进行分类,并根据成人治疗小组III指南测量那些达到最佳胆固醇水平的患者比例。

方法

审计使用了2005年1月1日至2007年12月31日的记录。在意大利南部农村地区的10名家庭医生的电子临床记录中输入电子搜索关键词,以查找诊断为高胆固醇血症或正在接受高胆固醇血症治疗的患者。从这些家庭医生登记的患者队列中随机选择了194名高胆固醇血症患者。对于已有心血管疾病的患者,低密度脂蛋白胆固醇(LDL-C)目标水平为100mg/dL(2.6mmol/L);对于有≥2个危险因素的患者,目标水平为130mg/dL(3.3mmol/L);对于所有其他患者,目标水平为160mg/dL(4.1mmol/L)。关于治疗效果的结果分类如下:(1)达标,LDL-C低于或等于所属类别的水平;(2)控制不佳,高于LDL-C目标水平1-30mg/dL(0.03-0.78mmol/L);(3)控制极差,高于LDL-C目标水平≥31mg/dL(≥0.8mmol/L)。

结果

纳入研究的高胆固醇血症患者的平均年龄为62.0±9.0岁;55%为男性,30%为吸烟者,71.3%患有高血压,46.3%患有糖尿病,39.9%肥胖,31.9%有冠心病家族史。I类(冠心病个人史、心血管风险≥20、糖尿病)有114名受试者有LDL-C目标水平。在这些患者中,24.6%达标,30.7%控制不佳,44.7%控制极差。采用意大利心脏项目所采用的评分系统检查的受试者中,共有42.3%的人心血管风险水平在5%至19%之间,没有资格免费获得降脂药物处方。

结论

这些数据表明,在这个农村地区,心血管风险高的患者的胆固醇管理并不总是最佳的。意大利的医疗保健规定似乎是药物处方的一个障碍,并且可能影响LDL-C的最佳控制。

相似文献

1
Audit of cholesterol management among primary care patients in rural southern Italy.意大利南部农村地区初级保健患者胆固醇管理情况的审计
Rural Remote Health. 2013 Oct-Dec;13(4):2225. Epub 2013 Dec 1.
2
[Achievement of the therapeutic goals for dyslipidemia in clinical practice: results of a survey among general practice physicians from Lombardy].[临床实践中血脂异常治疗目标的达成情况:来自伦巴第地区全科医生的调查结果]
Ital Heart J. 2003 Dec;4 Suppl 7:47S-57S.
3
Treatment of hypercholesterolemia in patients with diabetes at a family practice office.在家庭医疗诊所对糖尿病患者进行高胆固醇血症的治疗。
Del Med J. 2003 Nov;75(11):415-20.
4
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中,以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
5
Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care.在初级保健中,使用瑞舒伐他汀治疗高胆固醇血症患者,实现建议的低密度脂蛋白胆固醇目标及与目标达标相关的因素。
Curr Med Res Opin. 2013 Jul;29(7):751-60. doi: 10.1185/03007995.2013.802683.
6
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.近期临床试验对美国国家胆固醇教育计划成人治疗专家组第三次指南的影响。
J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. doi: 10.1016/j.jacc.2004.07.001.
7
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.近期临床试验对美国国家胆固醇教育计划成人治疗专家组第三次指南的影响。
Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. doi: 10.1161/01.ATV.0000133317.49796.0E.
8
Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.瑞舒伐他汀10毫克/天与阿托伐他汀10毫克/天对高危成年人影响的12周多中心随机开放标签比较:一项探索性研究
Clin Ther. 2004 Nov;26(11):1821-33. doi: 10.1016/j.clinthera.2004.11.015.
9
Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).阿托伐他汀在患有严重血脂异常及心血管疾病或心血管疾病危险因素的女性中实现国家胆固醇教育计划低密度脂蛋白目标的疗效:女性阿托伐他汀胆固醇试验(WATCH)。
Am Heart J. 2001 Jun;141(6):949-56. doi: 10.1067/mhj.2001.115588.
10
Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).指南与实践之间的差距:开始他汀类药物治疗的原发性高胆固醇血症患者治疗目标的达成情况。4E注册研究(包括医生经验与评估的心血管和脑血管事件疗效计算与测量)的结果
Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):776-83. doi: 10.1097/01.hjr.0000189805.76482.6e.